JavaScript is disabled for your browser. Some features of this site may not work without it.
Views
Total Views
| Views | |
|---|---|
| Efficacy ...(legacy) | 307 |
| Efficacy ... | 165 |
Total Views Per Month
| August 2022 | September 2022 | October 2022 | November 2022 | December 2022 | January 2023 | February 2023 | |
|---|---|---|---|---|---|---|---|
| Efficacy ... | 2 | 2 | 5 | 1 | 9 | 4 | 0 |
Country Views
| Country | Views |
| United States | 349 |
| Germany | 29 |
| China | 25 |
| South Africa | 24 |
| United Kingdom | 15 |
| Russia | 7 |
| France | 5 |
| Italy | 4 |
| Finland | 3 |
| Japan | 2 |
| Brazil | 1 |
| Peru | 1 |
| Thailand | 1 |
| Taiwan | 1 |
| Ukraine | 1 |
City Views
| Views | |
|---|---|
| Ashburn | 73 |
| Redmond | 53 |
| Seattle | 41 |
| Sunnyvale | 24 |
| Beijing | 18 |
| Mountain View | 8 |
| Johannesburg | 7 |
| Cape Town | 6 |
| Woodbridge | 6 |
| Southend | 5 |
Downloads
Total Downloads
| Downloads |
|---|
Total Downloads Per Month
| August 2022 | September 2022 | October 2022 | November 2022 | December 2022 | January 2023 | February 2023 | |
|---|---|---|---|---|---|---|---|
| Colhoun_Efficacy_safety_of_alirocumab_2014.pdf | 0 | 9 | 3 | 0 | 6 | 2 | 0 |
Country Downloads
| Country | Downloads |
| United States | 180 |
| Germany | 3 |
| China | 31 |
| United Kingdom | 3 |
| Russia | 40 |
| France | 3 |
| Peru | 1 |